RE: POP PK study in pediatrics
From: Bhattaram, Atul BhattaramA@cder.fda.gov
Subject: RE:[NMusers] POP PK study in pediatrics
Date: Tue, June 1, 2004 11:24 am
Hello Tata
It depends on the prior information you have on your compound. You could do simulations and evaluate various scenarios.
Venkatesh Atul Bhattaram
Pharmacometrics
DPE-1, OCPB
CDER, FDA.
_______________________________________________________